Peptide antimicrobial agents

Clinical Microbiology Reviews

Volumn 19, Issue 3, 2006, Pages 491-511

  Jenssen, Håvard ^a   Hamill, Pamela ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; ANTIFUNGAL AGENT; ANTIPARASITIC AGENT; ANTIVIRUS AGENT; BETA DEFENSIN 2; BREVININ; BUFORIN II; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CECROPIN A; CPI 226; DERMASEPTIN; HEPARAN SULFATE; HISTATIN; INDOLICIDIN; ISEGANAN; LACTOFERRICIN; MAGAININ 2; MBI 226; MELITTIN; MX 594 AN; PEPTIDE; PEXIGANAN ACETATE; POLYPEPTIDE ANTIBIOTIC AGENT; POLYPHEMUSIN; PROTEGRIN; TACHYPLESIN; TENECIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS GLYCOPROTEIN;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; BACTERIAL INFECTION; CELL INTERACTION; CELL SPREADING; CELL STIMULATION; CLINICAL TRIAL; HOST CELL; HOST RESISTANCE; HUMAN; IMPETIGO; MEMBRANE PERMEABILITY; MUCOSA INFLAMMATION; NONHUMAN; PROSTAGLANDIN RELEASE; REVIEW; TARGET CELL; VIRUS ENVELOPE;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTIPARASITIC AGENTS; ANTIVIRAL AGENTS; CATTLE; DEFENSINS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RABBITS;

EID: 33746532309     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.00056-05     Document Type: Review

References (280)

1. Aboudy, Y., E. Mendelson, I. Shalit, R. Bessalle, and M. Fridkin. 1994. Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2. Int. J. Pept. Protein Res. 43:573-582.
2. Alberola, J., A. Rodriguez, O. Francino, X. Roura, L. Rivas, and D. Andreu. 2004. Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis. Antimicrob. Agents Chemother. 48:641-643.
3. Albiol Matanic, V. C., and V. Castilla. 2004. Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. Int. J. Antimicrob. Agents 23:382-389.
4. Andersen, J. H., H. Jenssen, and T. J. Gutteberg. 2003. Lactoferrin and lactoferricin inhibit herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. Antiviral Res. 58:209-215.
5. Andersen, J. H., H. Jenssen, K. Sandvik, and T. J. Gutteberg. 2004. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface. J. Med. Virol. 74:262-271.
6. Andersen, J. H., S. A. Osbakk, L. H. Vorland, T. Traavik, and T. J. Gutteberg. 2001. Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res. 51:141-149.
7. Andersson, E., V. Rydengard, A. Sonesson, M. Morgelin, L. Bjorck, and A. Schmidtchen. 2004. Antimicrobial activities of heparin-binding peptides. Eur. J. Biochem. 271:1219-1226.
8. Argyris, E. G., E. Acheampong, G. Nunnari, M. Mukhtar, K. J. Williams, and R. J. Pomerantz. 2003. Human immunodeficiency virus type I enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts. J. Virol. 77:12140-12151.
9. Avrahami, D., and Y. Shai. 2003. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action. Biochemistry 42:14946-14956.
10. Ayabe, T., D. P. Satchell, C. L. Wilson, W. C. Parks, M. E. Selsted, and A. J. Ouellette. 2000. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 1:113-118.
11. Bachere, E., Y. Gueguen, M. Gonzalez, J. de Lorgeril, J. Garnier, and B. Romestand. 2004. Insights into the anti-microbial defense of marine invertebrates: the penaeid shrimps and the oyster Crassostrea gigas. Immunol. Rev. 198:149-168.
12. Bals, R., X. Wang, Z. Wu, T. Freeman, V. Bafna, M. Zasloff, and J. M. Wilson. 1998. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Investig. 102:874-880.
13. Barbault, F., C. Landon, M. Guenneugues, J. P. Meyer, V. Schott, J. L. Dimarcq, and F. Vovelle. 2003. Solution structure of Alo-3: a new knottin-type antifungal peptide from the insect Acrocinus longimanus. Biochemistry 42:14434-14442.
14. Barth, H., C. Schafer, M. I. Adah, F. Zhang, R. J. Linhardt, H. Toyoda, A. Kinoshita-Toyoda, T. Toida, T. H. Van Kuppevelt, E. Depla, F. Von Weizsacker, H. E. Blum, and T. F. Baumert. 2003. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 278:41003-41012.
15. Bastian, A., and H. Schafer. 2001. Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro. Regul. Pept. 101:157-161.
16. Belaid, A., M. Aouni, R. Khelifa, A. Trabelsi, M. Jemmali, and K. Hani. 2002. In vitro antiviral activity of dermaseptins against herpes simplex virus type 1. J. Med. Virol. 66:229-234.
17. Bellamy, W., H. Wakabayashi, M. Takase, K. Kawase, S. Shimamura, and M. Tomita. 1993. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med. Microbiol. Immunol. 182:97-105.
18. Benincasa, M., B. Skerlavaj, R. Gennaro, A. Pellegrini, and M. Zanetti. 2003. In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs. Peptides 24:1723-1731.
19. Bernfield, M., R. Kokenyesi, M. Kato, M. T. Hinkes, J. Spring, R. L. Gallo, and E. J. Lose. 1992. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8:365-393.
20. Boehr, D. D., K. A. Draker, K. Koteva, M. Bains, R. E. Hancock, and G. D. Wright. 2003. Broad-spectrum peptide inhibitors of aminoglycoside antibiotic resistance enzymes. Chem. Biol. 10:189-196.
21. Boman, H. G. 1995. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 13:61-92.
22. Boman, H. G., B. Agerberth, and A. Boman. 1993. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect. Immun. 61:2978-2984.
23. Bowdish, D. M., D. J. Davidson, and R. E. Hancock. 2005. A re-evaluation of the role of host defence peptides in mammalian immunity. Curr. Protein Pept. Sci. 6:35-51.
24. Bowdish, D. M., D. J. Davidson, Y. E. Lau, K. Lee, M. G. Scott, and R. E. Hancock. 2005. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 77:451-459.
25. Bowdish, D. M., D. J. Davidson, M. G. Scott, and R. E. Hancock. 2005. Immunomodulatory activities of small host defense peptides. Antimicrob. Agents Chemother. 49:1727-1732.
26. Bowdish, D. M., D. J. Davidson, D. P. Speert, and R. E. Hancock. 2004. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J. Immunol. 172:3758-3765.
27. Bowdish, D. M., and R. E. Hancock. 2005. Anti-endotoxin properties of cationic host defence peptides and proteins. J. Endotoxin Res. 11:230-236.
28. Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
29. Brotz, H., G. Bierbaum, P. E. Reynolds, and H. G. Sahl. 1997. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Eur. J. Biochem. 246:193-199.
30. Brown, K. L., and R. E. Hancock. 2006. Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. 18:24-30.
31. Brumfitt, W., M. R. Salton, and J. M. Hamilton-Miller. 2002. Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J. Antimicrob. Chemother. 50:731-734.
32. Bucki, R., J. J. Pastore, P. Randhawa, R. Vegners, D. J. Weiner, and P. A. Janmey. 2004. Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin. Antimicrob. Agents Chemother. 48:1526-1533.
33. Bulet, P., R. Stocklin, and L. Menin. 2004. Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev. 198:169-184.
34. Camejo, E. H., B. Rosengren, G. Camejo, P. Sartipy, G. Fager, and G. Bondjers. 1995. Interferon gamma binds to extracellular matrix chondroitin-sulfate proteoglycans, thus enhancing its cellular response. Arterioscler. Thromb. Vasc. Biol. 15:1456-1465.
35. Carmona, M. J., A. Molina, J. A. Fernandez, J. J. Lopez-Fando, and F. Garcia-Olmedo. 1993. Expression of the alpha-thionin gene from barley in tobacco confers enhanced resistance to bacterial pathogens. Plant J. 3:457-462.
36. Chan, Y. R., and R. L. Gallo. 1998. PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130(Cas). J. Biol. Chem. 273:28978-28985.
37. Chang, T. L., J. Vargas, Jr., A. DelPortillo, and M. E. Klotman. 2005. Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. J. Clin. Investig. 115:765-773.
38. Chatterjee, S., D. K. Chatterjee, R. H. Jani, J. Blumbach, B. N. Ganguli, N. Kiesel, M. Limbert, and G. Seibert. 1992. Mersacidin, a new antibiotic from Bacillus. In vitro and in vivo antibacterial activity. J. Antibiot. (Tokyo) 45:839-845.
39. Chatterjee, S., S. Chatterjee, S. J. Lad, M. S. Phansalkar, R. H. Rupp, B. N. Ganguli, H. W. Fehlhaber, and H. Kogler. 1992. Mersacidin, a new antibiotic from Bacillus. Fermentation, isolation, purification and chemical characterization. J. Antibiot. (Tokyo) 45:832-838.
40. Chertov, O., D. F. Michiel, L. Xu, J. M. Wang, K. Tani, W. J. Murphy, D. L. Longo, D. D. Taub, and J. J. Oppenheim. 1996. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271:2935-2940.
41. Cho, Y., J. S. Turner, N. N. Dinh, and R. I. Lehrer. 1998. Activity of protegrins against yeast-phase Candida albicans. Infect. Immun. 66:2486-2493.
42. Cole, A. M., T. Hong, L. M. Boo, T. Nguyen, C. Zhao, G. Bristol, J. A. Zack, A. J. Waring, O. O. Yang, and R. I. Lehrer. 2002. Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc. Natl. Acad. Sci. USA 99:1813-1818.
43. Cotter, P. D., C. Hill, and R. P. Ross. 2005. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3:777.
44. Cunliffe, R. N., and Y. R. Mahida. 2004. Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J. Leukoc. Biol. 75:49-58.
45. Daher, K. A., M. E. Selsted, and R. I. Lehrer. 1986. Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60:1068-1074.
46. Dathe, M., and T. Wieprecht. 1999. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta 1462:71-87.
47. Davidson, D. J., A. J. Currie, G. S. Reid, D. M. Bowdish, K. L. MacDonald, R. C. Ma, R. E. Hancock, and D. P. Speert. 2004. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 172:1146-1156.
48. Davis, A. J., and L. Kedzierski. 2005. Recent advances in antileishmanial drug development. Curr. Opin. Investig. Drugs 6:163-169.
49. De Clercq, E. 2004. Antiviral drugs in current clinical use. J. Clin. Virol. 30:115-133.
50. De Lucca, A. J., J. M. Bland, T. J. Jacks, C. Grimm, and T. J. Walsh. 1998. Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin. Med. Mycol. 36:291-298.
51. De Lucca, A. J., and T. J. Walsh. 1999. Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob. Agents Chemother. 43:1-11.
52. Diaz-Achirica, P., J. Ubach, A. Guinea, D. Andreu, and L. Rivas. 1998. The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide. Biochem. J. 330:453-460.
53. DiGabriele, A. D., I. Lax, D. I. Chen, C. M. Svahn, M. Jaye, J. Schlessinger, and W. A. Hendrickson. 1998. Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature 393:812-817.
54. Dorschner, R. A., V. K. Pestonjamasp, S. Tamakuwala, T. Ohtake, J. Rudisill, V. Nizet, B. Agerberth, G. H. Gudmundsson, and R. L. Gallo. 2001. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Investig. Dermatol. 117:91-97.
55. Drobni, P. 2005. Papillomavirus binding and entry. The heparan sulfate receptor and inhibition by lactoferrin. Doctoral dissertation. Umea University, Umea, Sweden.
56. Duits, L. A., B. Ravensbergen, M. Rademaker, P. S. Hiemstra, and P. H. Nibbering. 2002. Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology 106:517-525.
57. Ehrenstein, G., and H. Lecar. 1977. Electrically gated ionic channels in lipid bilayers. Q. Rev. Biophys. 10:1-34.
58. Elsbach, P. 2003. What is the real role of antimicrobial polypeptides that can mediate several other inflammatory responses? J. Clin. Investig. 111:1643-1645.
59. Epple, P., K. Apel, and H. Bohlmann. 1997. Overexpression of an endogenous thionin enhances resistance of Arabidopsis against Fusarium oxysporum. Plant Cell 9:509-520.
60. Faber, C., H. P. Stallmann, D. M. Lyaruu, U. Joosten, C. von Eiff, A. van Nieuw Amerongen, and P. I. Wuisman. 2005. Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model. Antimicrob. Agents Chemother. 49:2438-2444.
61. Falla, T. J., D. N. Karunaratne, and R. E. Hancock. 1996. Mode of action of the antimicrobial peptide indolicidin. J. Biol. Chem. 271:19298-1931)3.
62. Fang, X. M., Q. Shu, Q. X. Chen, M. Book, H. G. Sahl, A. Hoeft, and F. Stuber. 2003. Differential expression of alpha-and beta-defensins in human peripheral blood. Eur. J. Clin. Investig. 33:82-87.
63. Fennell, J. F., W. H. Shipman, and L. J. Cole. 1968. Antibacterial action of melittin, a polypeptidc from bee venom. Proc. Soc. Exp. Biol. Med. 127:707-710.
64. Friedrich, C. L., D. Moyles, T. J. Beveridge, and R. E. Hancock. 2000. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 44:2086-2092.
65. Friedrich, C. L., A. Rozek, A. Patrzykat, and R. E. Hancock. 2001. Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria. J. Biol. Chem. 276:24015-24022.
66. Frohm, M., B. Agerherth, G. Ahangari, M. Stahle-Backdahl, S. Liden, H. Wigzell, and G. H. Gudmundsson. 1997. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272:15258-15263.
67. Fromm, J. R., R. E. Hileman, E. E. Caldwell, J. M. Weiler, and R. J. Linhardt. 1995. Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. Arch. Biochem. Biophys. 323:279-287.
68. Fu, H., A. Bjorstad, C. Dahlgren, and J. Bylund. 2004. A bactericidal cecropin-A peptide with a stabilized alpha-helical structure possess an increased killing capacity but no proinflammatory activity. Inflammation 28:337-343.
69. Fujimura, M., M. Ideguchi, Y. Minami, K. Watanabe, and K. Tadera. 2004. Purification, characterization, and sequencing of novel antimicrobial peptides, Tu-AMP 1 and Tu-AMP 2, from bulbs of tulip (Tulipa gesneriana L.). Biosci. Biotechnol. Biochem. 68:571-577.
70. Ganz, T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3:710-720.
71. Ganz, T., M. E. Selsted, and R. I. Lehrer. 1986. Antimicrobial activity of phagocyte granule proteins. Semin. Respir. Infect. 1:107-117.
72. Garcia-Olmedo, F., A. Molina, J. M. Alamillo, and P. Rodriguez- Palenzuela. 1998. Plant defense peptides. Biopolymers 47:479-491.
73. Gazit, E., I. R. Miller, P. C. Biggin, M. S. Sansom, and Y. Shai. 1996. Structure and orientation of the mammalian antibacterial peptide ceeropin P1 within phospholipid membranes. J. Mol. Biol. 258:860-870.
74. Ge, Y., D. L. MacDonald, K. J. Holroyd, C. Thornsberry, H. Wexler, and M. Zasloff. 1999. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob. Agents Chemother. 43:782-788.
75. Gennaro, R., B. Skerlavaj, and D. Romeo. 1989. Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect. Immun. 57:3142-3146.
76. Gesell, J., M. Zasloff, and S. J. Opella. 1997. Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution. J. Biomol. NMR 9:127-135.
77. Giansanti, F., M. T. Massucci, M. F. Giardi, F. Nozza, E. Pulsinelli, C. Nicollni, D. Botti, and G. Antonini. 2005. Antiviral activity of ovotransferrin derived peptides. Biochem. Biophys. Res. Commun. 331:69-73.
78. Giles, F. J., R. Rodriguez, D. Weisdorf, J. R. Wingard, P. J. Martin, T. R. Fleming, S. L. Goldberg, E. J. Anaissle, B. J. Bolwell, N. J. Chao, T. C. Shea, M. M. Brunvand, W. Vaughan, F. Petersen, M. Schubert, H. M. Lazarus, R. T. Maziarz, M. Silverman, R. A. Beveridge, R. Redman, J. G. Pulliam, P. Devitt-Risse, H. J. Fuchs, and D. D. Hurd. 2004. A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy. Leukoc. Res. 28:559-565.
79. Gough, M., R. E. Hancock, and N. M. Kelly. 1996. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect. Immun. 64:4922-4927.
80. Gropp, R., M. Frye, T. O. Wagner, and J. Bargon. 1999. Epithelial defensins impair adenoviral infection: implication for adenovirus-mediated gene therapy. Hum. Gene Ther. 10:957-964.
81. Gudmundsson, G. H., B. Agerherth, J. Odeberg, T. Bergman, B. Olsson, and R. Salcedo. 1996. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238:325-332.
82. Guerrero, E., J. M. Saugar, K. Matsuzaki, and L. Rivas. 2004. Role of positional hydrophobicity in the leishmanicidal activity of magainin 2. Antimicrob. Agents Chemother. 48:2980-2986.
83. Ha, S. C., K. Min, J. C. Koo, Y. Kim, D. J. Yun, M. J. Cho, and K. K. Kim. 2001. Crystallization and preliminary crystallographic studies of an antimicrobial protein from Pharbitis nil. Acta Crystallogr. D 57:263-265.
84. Hahermann, E., and J. Jentsch. 1967. Sequence analysis of melittin from tryptic and peptic degradation products. Hoppe-Seyler's Z. Physiol. Chem. 348:37-50.
85. Hallock, K. J., D, K. Lee, and A. Ramamoorthy. 2003. MS1-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. Biophys. J. 84:31152-3060.
86. Hancock, R. E. 2001. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1:156-164.
87. Hancock, R. E. 1997. Peptide antibiotics. Lancet 349:418-422.
88. Hancock, R. E., and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
89. Hancock, R. E., and G. Diamond. 2000. The rule of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8:402-410.
90. Hancock, R. E., and R. Lehrer. 1998. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16:82-88.
91. Hancock, R. E., and A. Patrzykat. 2002. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr. Drug Targets Infect. Disord. 2:79-83.
92. Hancock, R. E., and A. Rozek. 2002. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 206:143-149.
93. Haukland, H. H., H. Ulvatne, K. Sandvik, and L. H. Vorland. 2001. The antimicrobial peptides lacloferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm. FEBS Lett. 508:389-39.3.
94. He, K., S. J. Ludtke, D. L. Worcester, and H. W. Huang. 1996. Neutron scattering in the plane of membranes: structure of alamethicin pores. Biophys. J. 70:2659-2666.
95. Heller, W. T., A. J. Waring, R. I. Lehrer, and H. W. Huang. 1998. Multiple states of beta-sheet peptide protegrin in lipid bilayers. Biochemistry 37:17331-17338.
96. Helmerhorst, E. J., P. Breeuwer, W. van't Hof, E. Walgreen-Weterings, L. C. Oomen, E. C. Veerman, A. V. Amerongen, and T. Abee. 1999. The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J. Biol. Chem. 274:7286-7291.
97. Helmerhorst, E. J., R. F. Troxler, and F. G. Oppenheim. 2001. The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc. Natl. Acad. Sci. USA 98:14637-14642.
98. Henzler Wildman, K. A., D. K. Lee, and A. Ramamoorthy. 2003. Mechanism of lipid bilayer disruption by the human antimicrobial peptide. LL-37. Biochemistry 42:6545-6558.
99. Hileman, R. E., J. R. Fromm, J. M. Weiler, and R. J. Linhardt. 1998. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 20:156-167.
100. Hilpert, K., R. Volkmer-Engert, T. Walter, and R. E. Hancock. 2005. High-throughput generation of small antibacterial peptides with improved activity. Nat. Biotechnol. 23:1008-1012.
101. Hoogewerf, A. J., G. S. Kuschert, A. E. Proudfoot, F. Borlat, I. Clark-Lewis, C. A. Power, and T. N. Wells. 1997. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36:13570-13578.
102. Home, W. S., C. M. Wiethoff, C. Cui, K. M. Wilcoxen, M. Amorin, M. R. Ghadiri, and G. R. Nemerow. 2005. Antiviral cyclic D,L-alpha-peptides: targeting a general biochemical pathway in virus infections. Bioorg. Med. Chem. 13:5145-5153.
103. Houston, M. E., Jr., L. H. Kondejewski, D. N. Karunaratne, M. Gough, S. Fidai, R. S. Hodges, and R. E. Hancock. 1998. Influence of preformed alpha-helix and alpha-helix induction on the activity of cationic antimicrobial peptides. J. Pept. Res. 52:81-88.
104. Hsu, C. H., C. Chen, M. L. Jou, A. Y. Lee, Y. C. Lin, Y. P. Yu, W. T. Huang, and S. H. Wu. 2005. Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA. Nucleic Acids Res. 33:4053-4064.
105. Huang, R. H., Y. Xiang, G. Z. Tu, Y. Zhang, and D. C. Wang. 2004. Solution structure of Eucommia antifungal peptide: a novel structural model distinct with a tive-disulfide motif. Biochemistry 43:6005-6012.
106. Hultmark, D., A. Engstrom, H. Bennich, R. Kapur, and H. G. Boman. 1982. Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae. Eur. J. Biochem. 127:207-217.
107. Hunter, H. N., A. R. Demcoe, H. Jenssen, T. J. Gutteberg, and H. J. Vogel. 2005. Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent. Antimicrob. Agents Chemother. 49:3387-3395.
108. Huttner, K. M., and C. L. Bevins. 1999. Antimicrobial peptides as mediators of epithelial host defense. Pediatr. Res. 45:785-794.
109. Hutton, R. D., D. L. Ewert, and G. R. French. 1973. Differentiation of types 1 and 2 herpes simplex virus by plaque inhibition with sulfated polyanions. Proc. Soc. Exp. Biol. Med. 142:27-29.
110. Iida, J., A. M. Meijne, T. R. Oegema, Jr., T. A. Yednock, N. L. Kovach, L. T. Furcht, and J. R. McCarthy. 1998. A role of chondroitin sulfate glycosaminoglycan binding site in alpha4beta1 integrin-mediated melanoma cell adhesion. J. Biol. Chem. 273:5955-5962.
111. Imler, J. L., and P. Bulet. 2005. Antimicrobial peptides in Drosophila: structures, activities and gene regulation. Chem. Immunol. Allergy 86:1-21.
112. Iozzo, R. V., and A. D. Murdoch. 1996. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J. 10:598-614.
113. Ishimoto, H., H. Mukae, Y. Date, T. Shimbara, M. S. Mondal, J. Ashitani, T. Hiratsuka, S. Kubo, S. Kohno, and M. Nakazato. 2006. Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia. Eur. Respir. J. 27:253-260.
114. Iwanaga, S., and S. Kawabata. 1998. Evolution and phylogeny of defense molecules associated with innate immunity in horseshoe crab. Front. Biosci. 3:D973-D984.
115. Jahn, R., and T. C. Sudhof. 1999. Membrane fusion and exocytosis. Annu. Rev. Biochem. 68:863-911.
116. James, S., B. F. Gibbs, K. Toney, and H. P. Bennett. 1994. Purification of antimicrobial peptides from an extract of the skin of Xenopus laevis using heparin-affinity HPLC: characterization by ion-spray mass spectrometry. Anal. Biochem. 217:84-90.
117. Javadpour, M. M., and M. D. Berkley. 1997. Self-assembly of designed antimicrobial peptides in solution and micelles. Biochemistry 36:9540-9549.
118. Jenssen, H. 2005. Anti herpes simplex virus activity of lactoferrin/lactoferricin-an example of antiviral activity of antimicrobial protein/peptide. Cell Mol. Life Sci. 62:3002-3013.
119. Jenssen, H., J. H. Andersen, D. Mantzilas, and T. J. Gutteberg. 2004. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus. Antiviral Res. 64:119-126.
120. Jenssen, H., J. H. Andersen, L. Uhlin-Hansen, T. J. Gutteberg, and O. Rekdal. 2004. Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate. Antiviral Res. 61:101-109.
121. Jenssen, H., T. J. Gutteberg, and T. Lejon. 2005. Modelling of anti-HSV activity of lactoferricin analogues using amino acid descriptors. J. Pept. Sci. 11:97-103.
122. Jenssen, H., T. J. Gutteberg, and T. Lejon. 2006. Modelling the anti-herpes simplex virus activity of small cationic peptides using amino acid descriptors. J. Pept. Res. 66(Suppl. 1):48-56.
123. Kanyshkova, T. G., D. V. Semenov, V. N. Buneva, and G. A. Nevinsky. 1999. Human milk lactoferrin binds two DNA molecules with different affinities. FEBS Lett. 451:235-237.
124. Kavanagh, K., and S. Dowd. 2004. Histatins: antimicrobial peptides with therapeutic potential. J. Pharm. Pharmacol. 56:285-289.
125. Kim, D. H., D. G. Lee, K. L. Kim, and Y. Lee. 2001. Internalization of tenecin 3 by a fungal cellular process is essential for its fungicidal effect on Candida albicans. Eur. J. Biochem. 268:4449-4458.
126. Kim, D. H., Y. T. Lee, Y. J. Lee, J. H. Chung, B. L. Lee, B. S. Choi, and Y. Lee. 1998. Bacterial expression of tenecin 3, an insect antifungal protein isolated from Tenebrio molitor, and its efficient purification. Mol. Cells 8:786-789.
127. Kjellen, L., and U. Lindahl. 1991. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60:443-475.
128. Klaenhammer, T. R. 1988. Bacteriocins of lactic acid bacteria. Biochimic 70:337-349.
129. Koczulla, R., G. von Degenfeld, C. Kupatt, F. Krotz, S. Zahler, T. Gloe, K. Issbrucker, P. Unterberger, M. Zaiou, C. Lebherz, A. Karl, P. Raake, A. Pfosser, P. Boekstegers, U. Welsch, P. S. Hiemstra, C. Vogelmeier, R. L. Gallo, M. Clauss, and R. Bals. 2003. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Investig. 111:1665-1672.
130. Kolset, S. O., and J. T. Gallagher. 1990. Proteoglycans in haemopoietic cells. Biochim. Biophys. Acta 1032:191-211.
131. Koo, J. C., B. Lee, M. E. Young, S. C. Koo, J. A. Cooper, D. Baek, C. O. Lim, S. Y. Lee, D. J. Yun, and M. J. Cho. 2004. Pn-AMP1, a plant defense protein, induces actin depolarization in yeasts. Plant Cell Physiol. 45:1669-1680.
132. Koradi, R., M. Billeter, and K. Wuthrich. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:51-55, 29-32.
133. Kragol, G., S. Lovas, G. Varadi, B. A. Condie, R. Hoffmann, and L. Otvos, Jr. 2001. The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. Biochemistry 40:3016-3026.
134. Krajewski, K., C. Marchand, Y. Q. Long, Y. Pommier, and P. P. Roller. 2004. Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin. Bioorg. Med. Chem. Lett. 14:5595-5598.
135. Kruszewska, D., H. G. Sahl, G. Bierbaum, U. Pag, S. O. Hynes, and A Ljungh. 2004. Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J. Antimicrob. Chemother. 54:648-653.
136. Kustanovich, I., D. E. Shalev, M. Mikhlin, L. Gaidukov, and A. Mor. 2002. Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives. J. Biol. Chem. 277:16941-16951.
137. Lamb, H. M., and L. R. Wiseman. 1998. Pexiganan acetate. Drugs 56:1047-1054.
138. Langeland, N., L. J. Moore, H. Holmsen, and L. Haarr. 1988. Interaction of polylysine with the cellular receptor for herpes simplex virus type 1. J. Gen. Virol. 69:1137-1145.
139. Lau, Y. E., A. Rozek, M. G. Scott, D. L. Goosney, D. J. Davidson, and R. E. Hancock. 2005. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect. Immun. 73:583-591.
140. Lee, D. G., K. S. Hahm, and S. Y. Shin. 2004. Structure and fungicidal activity of a synthetic antimicrobial peptide, P18, and its truncated peptides. Biotechnol. Lett. 26:337-341.
141. Lee, D. G., D. H. Kim, Y. Park, H. K. Kim, H. N. Kim, Y. K. Shin, C. H. Choi, and K. S. Hahm. 2001. Fungicidal effect of antimicrobial peptide, PMAP-23, isolated from porcine myeloid against Candida albicans. Biochem. Biophys. Res. Commun. 282:570-574.
142. Lee, D. G., H. K. Kim, S. A. Kim, Y. Park, S. C. Park, S. H. Jang, and K. S. Hahm. 2003. Fungicidal effect of indolicidin and its interaction with phospholipid membranes. Biochem. Biophys. Res. Commun. 305:305-310.
143. Lee, D. G., P. I. Kim, Y. Park, E. R. Woo, J. S. Choi, C. H. Choi, and K. S. Hahm. 2002. Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid. Biochem. Biophys. Res. Commun. 293:231-238.
144. Lee, D. G., Y. Park, I. Jin, K. S. Hahm, H. H. Lee, Y. H. Moon, and E. R. Woo. 2004. Structure-antiviral activity relationships of cecropin A-magainin 2 hybrid peptide and its analogues. J. Pept. Sci. 10:298-303.
145. Lee, P. H., J. A. Rudisill, K. H. Lin, L. Zhang, S. M. Harris, T. J. Falla, and R. L. Gallo. 2004. HB-107, a nonbacteriostatic fragment of the antimicrobial peptide cecropin B, accelerates murine wound repair. Wound Repair Regen. 12:351-358.
146. Lee, Y. T., D. H. Kim, J. Y. Suh, J. H. Chung, B. L. Lee, Y. Lee, and B. S. Choi. 1999. Structural characteristics of tenecin 3, an insect antifungal protein. Biochem. Mol. Biol. Int. 47:369-376.
147. Lehrer, R. I., A. Barton, K. A. Daher, S. S. Harwig, T. Ganz, and M. E. Selsted. 1989. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J. Clin. Investig. 84:553-561.
148. Lehrer, R. I., D. Szklarek, T. Ganz, and M. E. Selsted. 1985. Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity. Infect. Immun. 49:207-211.
149. Lemaitre, B., E. Nicolas, L. Michaut, J. M. Reichhart, and J. A. Hoffmann. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973-983.
150. Liu, S., H. Lu, J. Niu, Y. Xu, S. Wu, and S. Jiang. 2005. Different from the HIV fusion inhibitor C34, the anti-HIV drug fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120. J. Biol. Chem. 280:11259-11273.
151. Lookene, A., R. Savonen, and G. Olivecrona. 1997. Interaction of lipoproteins with heparan sulfate proteoglycans and with lipoprotein lipase. Studies by surface plasmon resonance technique. Biochemistry 36:5267-5275.
152. Lopez-Garcia, B., J. F. Marcos, C. Abad, and E. Perez-Paya. 2004. Stabilisation of mixed peptide/lipid complexes in selective antifungal hexapeptides. Biochim. Biophys. Acta 1660:131-137.
153. Lorin, C., H. Saidi, A. Belaid, A. Zairi, F. Baleux, H. Hocini, L. Belec, K. Hani, and F. Tangy. 2005. The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro. Virology 334:264-275.
154. Lupetti, A., A. Paulusma-Annema, S. Senesi, M. Campa, J. T. Van Dissel, and P. H. Nibbering. 2002. Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin. Antimicrob. Agents Chemother. 46:1634-1639.
155. Lustig, F., J. Hoebeke, G. Ostergren-Lunden, F. Velge-Roussel, G. Bondjers, U. Olsson, U. Ruetschi, and G. Fager. 1996. Alternative splicing determines the binding of platelet-derived growth factor (PDGF-AA) to glycosaminoglycans. Biochemistry 35:12077-12085.
156. Mandard, N., P. Sodano, H. Labbe, J. M. Bonmatin, P. Bulet, C. Hetru, M. Ptak, and F. Vovelle. 1998. Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimensional nuclear magnetic resonance data. Eur. J. Biochem. 256:404-410.
157. Mann, D. M., E. Romm, and M. Migliorini. 1994. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem. 269:23661-23667.
158. Mardberg, K., E. Trybala, F. Tufaro, and T. Bergstrom. 2002. Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells. J. Gen. Virol. 83:291-300.
159. Martin, E., T. Ganz, and R. I. Lehrer. 1995. Defensins and other endogenous peptide antibiotics of vertebrates. J. Leukoc. Biol. 58:128-136.
160. Masuda, M., H. Nakashima, T. Ueda, H. Naba, R. Ikoma, A. Otaka, Y. Terakawa, H. Tamamura, T. Ibuka, T. Murakami, et al. 1992. A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II). Biochem. Biophys. Res. Commun. 189:845-850.
161. Matsuzaki, K. 1998. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta 1376:391-400.
162. Matsuzaki, K., O. Murase, N. Fujii, and K. Miyajima. 1996. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry 35:11361-11368.
163. Mattick, A. T. R., and A. Hirsch. 1947. Further observations on an inhibitory substance (nisin) from lactic streptococci. Lancet ii:5-7.
164. McCann, K. B., A. Lee, J. Wan, H. Roginski, and M. J. Coventry. 2003. The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures. J. Appl. Microbiol. 95:1026-1033.
165. McManus, A. M., N. F. Dawson, J. D. Wade, L. E. Carrington, D. J. Winzor, and D. J. Craik. 2000. Three-dimensional structure of RK-1: a novel alpha-defensin peptide. Biochemistry 39:15757-15764.
166. Mettenleiter, T. C. 2002. Brief overview on cellular virus receptors. Virus Res. 82:3-8.
167. Mikloska, Z., and A. L. Cunningham. 2001. Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission. J. Virol. 75:11821-11826.
168. Moerman, L., S. Bosteels, W. Noppe, J. Willems, E. Clynen, L. Schoofs, K. Thevissen, J. Tytgat, J. Van Eldere, J. Van Der Walt, and F. Verdonck. 2002. Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa. Eur. J. Biochem. 269:4799-4810.
169. Moore, A. 2003. The big and small of drug discovery. Biotech versus pharma: advantages and drawbacks in drug development. EMBO Rep. 4:114-117.
170. Moore, K. S., S. Wehrli, H. Roder, M. Rogers, J. N. Forrest, Jr., D. McCrimmon, and M. Zasloff. 1993. Squalamine: an aminosterol antibiotic from the shark. Proc. Natl. Acad. Sci. USA 90:1354-1358.
171. Morimoto, M., H. Mori, T. Otake, N. Ueba, N. Kunita, M. Niwa, T. Murakami, and S. Iwanaga. 1991. Inhibitory effect of tachyplesin 1 on the proliferation of human immunodeficiency virus in vitro. Chemotherapy 37:206-211.
172. Murakami, M., T. Ohtake, R. A. Dorschner, B. Schlttek, C. Garhe, and R. L. Gallo. 2002. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J. Investig. Dermatol. 119:1090-1095.
173. Murakami, T., T. Nakajima, Y. Koyanagi, K. Tachibana, N. Fujii, H. Tamamura, N. Yoshida, M. Waki, A. Matsumoto, O. Yoshie, T. Kishimoto, N. Yamamoto, and T. Nagasawa. 1997. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J. Exp. Med. 186:1389-1393.
174. Murakami, T., M. Niwa, V. Tokunaga, T. Miyata, and S. Iwanaga. 1991. Direct virus inactivation of tachyplesin 1 and its isopeptides from horseshoe crab hemocytes. Chemotherapy 37:327-334.
175. Mygind, P. H., R. L. Fischer, K. M. Schnorr, M. T. Hansen, C. P. Sonksen, S. Ludvigsen, D. Raventos, S. Buskov, B. Christensen, L. De Maria, O. Taboureau, D. Yaver, S. G. Elvig-Jorgensen, M. V. Sorensen, B. E. Christensen, S. Kjaerulff, N. Frimodt-Moller, R. I. Lehrer, M. Zasloff, and H. H. Kristensen. 2005. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437:975-980.
176. Nagaoka, I., K. Kuwahara-Arai, H. Tamura, K. Hiramatsu, and M. Hirata. 2005. Augmentation of the bactericidal activities of human cathelicidin CAP 18/LL-37-derived antimicrobial peptides by amino acid substitutions. Inflamm. Res. 54:66-73.
177. Nakashima, H., M. Masuda, T. Murakami, Y. Koyanagi, A. Matsumoto, N. Fujii, and N. Yamamoto. 1992. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion. Antimicrob. Agents Chemother. 36:1249-1255.
178. Nakashima, H., N. Yamamoto, M. Masuda, and N. Fujii. 1993. Defensins inhibit HIV replication in vitro. AIDS 7:1129.
179. Narasimhan, M. L., B. Damsz, M. A. Coca, J. I. Ibeas, D. J. Yun, J. M. Pardo, P. M. Hasegawa, and R. A. Bressan. 2001. A plant defense response effector induces microbial apoptosis. Mol. Cell 8:921-930.
180. Nibbering, P. H., E. Ravensbergen, M. M. Welling, L. A. van Berkel, P. H. van Berkel, E. K. Pauwels, and J. H. Nuijens. 2001. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect. Immun. 69:1469-1476.
181. Nikawa, H., H. Fukushima, S. Makihira, T. Hamada, and L. P. Samaranayake. 2004. Fungicidal effect of three new synthetic cationic peptides against Candida albicans. Oral Dis. 10:221-228.
182. Olsson, U., G. Camejo, E. Hurt-Camejo, K. Elfsber, O. Wiklund, and G. Bondjers. 1997. Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the ApoB/E receptor. Arterioscler. Thromb. Vasc. Biol. 17:149-155.
183. Osapay, K., D. Tran, A. S. Ladokhin, S. H. White, A. H. Henschen, and M. E. Selsted. 2000. Formation and characterization of a single Trp-Trp cross-link in indolicidin that confers protease stability without altering antimicrobial activity. J. Biol. Chem. 275:12017-12022.
184. Otvos, L., Jr., I. O., M. E. Rogers, P. J. Consolvo, B. A. Condie, S. Lovas, P. Bulet, and M. Blaszczyk-Thurin. 2000. Interaction between heat shock proteins and antimicrobial peptides. Biochemistry 39:14150-14159.
185. Ourth, D. D., T. D. Lockey, and H. E. Renis. 1994. Induction of cecropin-like and attacin-like antibacterial but not antiviral activity in Heliothis virescens larvae. Biochem. Biophys. Res. Commun. 200:35-44.
186. Panyutich, A., J. Shi, P. L. Boutz, C. Zhao, and T. Ganz. 1997. Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infect. Immun. 65:978-985.
187. Park, C. B., H. S. Kim, and S. C. Kim. 1998. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 244:253-257.
188. Park, C. B., K. S. Yi, K. Matsuzaki, M. S. Kim, and S. C. Kim. 2000. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci. USA 97:8245-8250.
189. Park, K., D. Oh, S. Y. Shin, K. S. Hahm, and Y. Kim. 2002. Structural studies of porcine myeloid antibacterial peptide PMAP-23 and its analogues in DPC micelles by NMR spectroscopy. Biochem. Biophys. Res. Commun. 290:204-212.
190. Park, Y., S. H. Jang, D. G. Lee, and K. S. Hahm. 2004. Antinematodal effect of antimicrobial peptide, PMAP-23, isolated from porcine myeloid against Caenorhabditis elegans. J. Pept. Sci. 10:304-311.
191. Park, Y., D. G. Lee, and K. S. Hahm. 2004. HP(2-9)-magainin 2(1-12), a synthetic hybrid peptide, exerts its antifungal effect on Candida albicans by damaging the plasma membrane. J. Pept. Sci. 10:204-209.
192. Parker, K. H., C. P. Winlove, and A. Maroudas. 1988. The theoretical distributions and diffusivities of small ions in chondroitin sulphate and hyaluronate. Biophys. Chem. 32:271-282.
193. Patrzykat, A., C. L. Friedrich, L. Zhang, V. Mendoza, and R. E. W. Hancock. 2002. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother. 46:605-614.
194. Patterson-Delafield, J., R. J. Martinez, and R. I. Lehrer. 1980. Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism. Infect. Immun. 30:180-192.
195. Penco, S., S. Scarfi, M. Giovine, G. Damonte, E. Millo, B. Villaggio, M. Passalacqua, M. Pozzolini, C. Garre, and U. Benatti. 2001. Identification of an import signal for, and the nuclear localization of, human lactoferrin. Biotechnol. Appl. Biochem. 34:151-159.
196. Perez, A., Q. X. Li, P. Perez-Romero, G. Delassus, S. R. Lopez, S. Sutter, N. McLaren, and A. O. Fuller. 2005. A new class of receptor for herpes simplex virus has heptad repeat motifs that are common to membrane fusion proteins. J. Virol. 79:7419-7430.
197. Perez-Romero, P., and A. O. Fuller. 2005. The C terminus of the B5 receptor for herpes simplex virus contains a functional region important for infection. J. Virol. 79:7431-7437.
198. Pettersson, I., M. Kusche, K. Unger, H. Wlad, L. Nylund, U. Lindahl, and L. Kjellen. 1991. Biosynthesis of heparin. Purification of a 110-kDa mouse mastocytoma protein required for both glucosaminyl N-deacetylation and N-sulfation. J. Biol. Chem. 266:8044-8049.
199. Pietrantoni, A., M. G. Ammendolia, A. Tinari, R. Siciliano, P. Valenti, and F. Superti. 2006. Bovine lactoferrin peptidic fragments involved in inhibition of Echovirus 6 in vitro infection. Antiviral Res. 69:98-106.
200. Pouny, Y., D. Rapaport, A. Mor, P. Nicolas, and Y. Shai. 1992. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry 31:12416-12423.
201. Powers, J. P., and R. E. Hancock. 2003. The relationship between peptide structure and antibacterial activity. Peptides 24:1681-1691.
202. Powers, J. P., A. Rozek, and R. E. Hancock. 2004. Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I. Biochim. Biophys. Acta 1698:239-250.
203. Powers, J. P., A. Tan, A. Ramamoorthy, and R. E. Hancock. 2005. Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes. Biochemistry 44:15504-15513.
204. Putsep, K., G. Carlsson, H. G. Boman, and M. Andersson. 2002. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360:1144-1149.
205. Ramos-Onstns, S., and M. Aguade. 1998. Molecular evolution of the Cecropin multigene family in Drosophila. Functional genes vs. pseudogenes. Genetics 150:157-171.
206. Riley, M. A. 1998. Molecular mechanisms of bacteriocin evolution. Annu. Rev. Genet. 32:255-278.
207. Rinaldi, A. C. 2002. Antimicrobial peptides from amphibian skin: an expanding scenario. Curr. Opin. Chem. Biol. 6:799-804.
208. Robinson, W. E., Jr., B. McDougall, D. Tran, and M. E. Selsted. 1998. Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils. J. Leukoc. Biol. 63:94-100.
209. Roch, P., A. Besehin, and E. Bernard. 2004. Antiprotozoan and antiviral activities of non-cytotoxic truncated and variant analogues of mussel defensin. Evid Based Complement Alternat. Med. 1:167-174.
210. Rollins-Smith, L. A., C. Carey, J. Longcore, J. K. Doersam, A. Boutte, J. E. Bruzgal, and J. M. Conlon. 2002. Activity of antimicrobial skin peptides from ranid frogs against Batrachochytrium dendrobatidis, the chytrid fungus associated with global amphibian declines. Dev. Comp. Immunol. 26:471-479.
211. Roth, B. L., M. Poot, S. T. Yue, and P. J. Millard. 1997. Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain. Appl. Environ. Microbiol. 63:2421-2431.
212. Rozek, A., C. L. Friedrich, and R. E. Hancock. 2000. Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry 39:15765-15774.
213. Rozek, A., J. P. Powers, C. L. Friedrich, and R. E. Hancock. 2003. Structure-based design of an indolicidin peptide analogue with increased protease stability. Biochemistry 42:14130-14138.
214. Salzman, N. H., D. Ghosh, K. M. Huttner, Y. Paterson, and C. L. Bevins. 2003. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422:522-526.
215. Sandgren, S., A. Wittrup, F. Cheng, M. Jonsson, E. Eklund, S. Busch, and M. Belting. 2004. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J. Biol. Chem. 279:17951-17956.
216. Sawai, M. V., H. P. Jia, L. Liu, V. Aseyev, J. M. Wiencek, P. B. McCray, Jr., T. Ganz, W. R. Kearney, and B. F. Tack. 2001. The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment. Biochemistry 40:3810-3816.
217. Schmidtchen, A., I. M. Frick, E. Andersson, H. Tapper, and L. Bjorck. 2002. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 46:157-168.
218. Schmidtchen, A., I. M. Frick, and L. Bjorck. 2001. Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol. Microbiol. 39:708-713.
219. Scott, M. G., D. J. Davidson, M. R. Gold, D. Bowdish, and R. E. Hancock. 2002. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169:3883-3891.
220. Scott, M. G., and R. E. Hancock. 2000. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit. Rev. Immunol. 20:407-431.
221. Selsted, M. E., and A. J. Ouellette. 2005. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6:551-557.
222. Shieh, M. T., D. WuDunn, R. I. Montgomery, J. D. Esko, and P. G. Spear. 1992. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116:1273-1281.
223. Shimazaki, K., T. Tazume, K. Uji, M. Tanaka, H. Kumura, K. Mikawa, and T. Shinto-Oka. 1998. Properties of a heparin-binding peptide derived from bovine lactoferrin. J. Dairy Sci. 81:2841-2849.
224. Simmaco, M., G. Mignogna, and D. Barra. 1998. Antimicrobial peptides from amphibian skin: what do they tell us? Biopolymers 47:435-450.
225. Sinha, S., N. Cheshenko, R. I. Lehrer, and B. C. Herold. 2003. NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2. Antimicrob. Agents Chemother. 47:494-500.
226. Sitaram, N., and R. Nagaraj. 1999. Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. Biochim. Biophys. Acta 1462:29-54.
227. Sitaram, N., C. Subbalakshmi, and R. Nagaraj. 2003. Indolicidin, a 13-residue basic antimicrobial peptide rich in tryptophan and proline, interacts with Ca(2+)-calmodulin. Biochem. Biophys. Res. Commun. 309:879-384.
228. Skehel, J. J., and D. C. Wiley. 1998. Coiled coils in both intracellular vesicle and viral membrane fusion. Cell 95:871-374.
229. Skerlavaj, B., R. Gennaro, L. Bagella, L. Merluzzi, A. Risso, and M. Zanetti. 1996. Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J. Biol. Chem. 271:28375-28381.
230. Skerlavaj, B., M. Scocchi, R. Gennaro, A. Risso, and M. Zanetti. 2001. Structural and functional analysis of horse cathelicidin peptides. Antimicrob. Agents Chemother. 45:715-722.
231. Song, B. H., G. C. Lee, M. S. Moon, Y. H. Cho, and C. H. Lee. 2001. Human cytomegalovirus binding to heparan sulfate proteoglycans on the cell surface and/or entry stimulates the expression of human leukocyte antigen class I. J. Gen. Virol. 82:2405-2413.
232. Song, Y. M., Y. Park, S. S. Lim, S. T. Yang, E. R. Woo, I. S. Park, J. S. Lee, J. I. Kim, K. S. Hahm, Y. Kim, and S. Y. Shin. 2005. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Biochemistry 44:12094-12106.
233. Spaar, A., C. Munster, and T. Salditt. 2004. Conformation of peptides in lipid membranes studied by x-ray grazing incidence scattering. Biophys. J. 87:396-407.
234. Spillmann, D. 2001. Heparan sulfate: anchor for viral intruders? Biochimie 83:811-817.
235. Steinberg, D. A., M. A. Hurst, C. A. Fujii, A. H. Kung, J. F. Ho, F. C. Cheng, D. J. Loury, and J. C. Fiddes. 1997. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. 41:1738-1742.
236. Steinstraesser, L., B. Tippler, J. Mertens, E. Lamme, H. H. Homann, M. Lehnhardt, O. Wildner, H. U. Steinau, and K. Uberla. 2005. Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides. Retrovirology 2:2.
237. Stenlund, P., M. J. Lindberg, and L. A. Tibell. 2002. Structural requirements for high-affinity heparin binding: alanine scanning analysis of charged residues in the C-terminal domain of human extracellular superoxide dismutase. Biochemistry 41:3168-3175.
238. Subbalakshmi, C., and N. Sitaram. 1998. Mechanism of antimicrobial action of indolicidin. FEMS Microbiol. Lett. 160:91-96.
239. Suzuki, T., S. Futaki, M. Niwa, S. Tanaka, K. Ueda, and Y. Sugiura. 2002. Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277:2437-2443.
240. Tamamura, H., T. Ishihara, A. Otaka, T. Murakami, T. Ibuka, M. Waki, A. Matsumoto, N. Yamamoto, and N. Fujii. 1996. Analysis of the interaction of an anti-HIV peptide, T22 ([Tyr5, 12, Lys7]-polyphemusin II), with gp120 and CD4 by surface plasmon resonance. Biochim. Biophys. Acta 1298:37-44.
241. Tamamura, H., T. Murakami, M. Masuda, A. Otaka, W. Takada, T. Ibuka, H. Nakashima, M. Waki, A. Matsumoto, N. Yamamoto, et al. 1994. Structure-activity relationships of an anti-HIV peptide, T22. Biochem. Biophys. Res. Commun. 205:1729-1735.
242. Tamamura, H., A. Otaka, T. Murakami, T. Ishihara, T. Ibuka, M. Waki, A. Matsumoto, N. Yamamoto, and N. Fujii. 1996. Interaction of an anti-HIV peptide, T22, with gp120 and CD4. Biochem. Biophys. Res. Commun. 219:555-559.
243. Tamamura, H., Y. Xu, T. Hattori, X. Zhang, R. Arakaki, K. Kanbara, A. Omagari, A. Otaka, T. Ibuka, N. Yamamoto, H. Nakashima, and N. Fujii. 1998. A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140. Biochem. Biophys. Res. Commun. 253:877-382.
244. Tang, Y. Q., J. Yuan, G. Osapay, K. Osapay, D. Tran, C. J. Miller, A. J. Ouellette, and M. E. Selsted. 1999. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science 286:498-502.
245. Terras, F. R., H. M. Schoofs, M. F. De Bolle, F. Van Leuven, S. B. Rees, J. Vanderleyden, B. P. Cammue, and W. F. Broekaert. 1992. Analysis of two novel classes of plant antifungal proteins from radish (Raphanus sativus L.) seeds. J. Biol. Chem. 267:15301-15309.
246. Territo, M. C., T. Ganz, M. E. Selsted, and R. Lehrer. 1989. Monocyte-chemotactic activity of defensins from human neutrophils. J. Clin. Investig. 84:2017-2020.
247. Tew, G. N., D. Liu, B. Chen, R. J. Doerksen, J. Kaplan, P. J. Carroll, M. L. Klein, and W. F. DeGrado. 2002. De novo design of biomimetic antimicrobial polymers. Proc. Natl. Acad. Sci. USA 99:5110-5114.
248. Trotti, A., A. Garden, P. Warde, P. Symonds, C. Langer, R. Redman, T. F. Pajak, T. R. Fleming, M. Henke, J. Bourhis, D. I. Rosenthal, E. Junor, A. Cmelak, F. Sheehan, J. Pulliam, P. Devitt-Risse, H. Fuchs, M. Chambers, B. O'Sullivan, and K. K. Ang. 2004. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int. J. Radiat. Oncol. Biol. Phys. 58:674-681.
249. Trybala, E., S. Olofsson, K. Mardberg, B. Svennerholm, K. Umemoto, J. C. Glorioso, and T. Bergstrom. 2004. Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells. Antiviral Res. 62:125-134.
250. Tytler, E. M., G. M. Anantharamaiah, D. E. Walker, V. K. Mishra, M. N. Palgunachari, and J. P. Segrest. 1995. Molecular basis for prokaryotic specificity of magainin-induced lysis. Biochemistry 34:4393-4401.
251. Uteng, M., H. H. Hauge, P. R. Markwick, G. Fimland, D. Mantzilas, J. Nissen-Meyer, and C. Muhle-Goll. 2003. Three-dimensional structure in lipid micelles of the pediocin-like antimicrobial peptide sakacin P and a sakacin P variant that is structurally stabilized by an inserted C-terminal disulfide bridge. Biochemistry 42:11417-11426.
252. Veerman, E. C., K. Nazmi, W. Van't Hof, J. G. Bolscher, A. L. Den Hertog, and A. V. Nieuw Amerongen. 2004. Reactive oxygen species play no role in the candidacidal activity of the salivary antimicrobial peptide histatin 5. Biochem. J. 381:447-452.
253. Viejo-Diaz, M., M. T. Andres, and J. F. Fierro. 2005. Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1. Antimicrob. Agents Chemother. 49:2583-2588.
254. Vives, R. R., A. Imberty, Q. J. Sattentau, and H. Lortat-Jacob. 2005. Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site. J. Biol. Chem. 280:21353-21357.
255. Wachinger, M., A. Kleinschmidt, D. Winder, N. von Pechmann, A. Ludvigsen, M. Neumann, R. Holle, B. Salmons, V. Erfie, and R. Brack-Werner. 1998. Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J. Gen. Virol. 79:731-740.
256. Wang, W., A. M. Cole, T. Hong, A. J. Waring, and R. I. Lehrer. 2003. Retrocyclin, an antiretroviral theta-defensin, is a lectin. J. Immunol. 170:4708-4716.
257. Wang, Z., and G. Wang. 2004. APD: the Antimicrobial Peptide Database. Nucleic Acids Res. 32:D590-D592.
258. Wilson, C. L., A. J. Ouellette, D. P. Satchell, T. Ayabe, Y. S. Lopez-Boado, J. L. Stratman, S. J. Hultgren, L. M. Matrisian, and W. C. Parks. 1999. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286:113-117.
259. Wu, M., E. Maier, R. Benz, and R. E. Hancock. 1999. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 38:7235-7242.
260. WuDunn, D., and P. G. Spear. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:52-58.
261. Xia, G., J. Chen, V. Tiwari, W. Ju, J. P. Li, A. Mulmstrom, D. Shukla, and J. Liu. 2002. Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J. Biol. Chem. 277:37912-37919.
262. Xiong, Y. Q., M. R. Yeaman, and A. S. Bayer. 1999. In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action. Antimicrob. Agents Chemother. 43:1111-1117.
263. Xu, Y., H. Tamamura, R. Arakaki, H. Nakashima, X. Zhang, N. Fujii, T. Uchiyama, and T. Hattori. 1999. Marked increase in anti-HIV activity, as well as inhibitory activity against HIV entry mediated by CXCR4, linked to enhancement of the binding ability of tachyplesin analogs to CXCR4. AIDS Res. Hum. Retroviruses. 15:419-427.
264. Yamaguchi, S., D. Huster, A. Waring, R. I. Lehrer, W. Kearney, B. F. Tack, and M. Hong. 2001. Orientation and dynamics of an antimicrobial peptide in the lipid bilayer by solid-state NMR spectroscopy. Biophys. J. 81:2203-2214.
265. Yang, D., A. Biragyn, D. M. Hoover, J. Lubkowski, and J. J. Oppenheim. 2004. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol. 22:181-215.
266. Yang, D., A. Biragyn, L. W. Kwak, and J. J. Oppenheim. 2002. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23:291-296.
267. Yang, L., T. A. Harroun, T. M. Weiss, L. Ding, and H. W. Huang. 2001. Barrel-stave model or toroidal model? A ease study on melittin pores. Biophys. J. 81:1475-1485.
268. Yang, N., M. B. Strom, S. M. Mekonnen, J. S. Svendsen, and O. Rekdal. 2004. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells. J. Pept. Sci. 10:37-46.
269. Yasin, B., M. Pang, J. S. Turner, Y. Cho, N. N. Dinh, A. J. Waring, R. I. Lehrer, and E. A. Wagar. 2000. Evaluation of the inactivation of infectious herpes simplex virus by host-defense peptides. Eur. J. Clin. Microbiol. Infect. Dis. 19:187-194.
270. Yasin, B., W. Wang, M. Pang, N. Cheshenko, T. Hong, A. J. Waring, B. C. Herold, E. A. Wagar, and R. I. Lehrer. 2004. Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J. Virol. 78:5147-5156.
271. Zanetti, M. 2004. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75:39-48.
272. Zasloff, M. 1987. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA 84:5449-5453.
273. Zasloff, M., B. Martin, and H. C. Chen. 1988. Antimicrobial activity of synthetic magainin peptides and several analogues. Proc. Natl. Acad. Sci. USA 85:910-913.
274. Zautner, A. E., U. Korner, A. Henke, C. Badorff, and M. Schmidtke. 2003. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection. J. Virol. 77:10071-10077.
275. Zelezetsky, I., U. Pag, H. G. Sahl, and A. Tossi. 2005. Tuning the biological properties of amphipathic alpha-helical antimicrobial peptides: rational use of minimal amino acid substitutions. Peptides 26:2368-2376.
276. Zhang, L., and T. J. Falla. 2006. Antimicrobial peptides-therapeutic potential. Expert Opin. Pharmacother. 7:653-663.
277. Zhang, L., J. Parente, S. M. Harris, D. E. Woods, R. E. W. Hancock, and T. J. Falla. 2005. Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob. Agents Chemother. 49:2921-2927.
278. Zhang, L., S. Parente, S. M. Harris, and T. J. Falla. 2004. Presented at the 24th General Meeting of the American Society of Microbiology, New Orleans, La.
279. Zhang, L., A. Rozek, and R. E. Hancock. 2001. Interaction of cationic antimicrobial peptides with model membranes. J. Biol. Chem. 276:35714-35722.
280. Zhang, L., M. G. Scott, H. Yan, L. D. Mayer, and R. E. Hancock. 2000. Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Biochemistry 39:14504-14514.